Drugs Home > Carfilzomib
Carfilzomib is given intravenously once a day for two days in a row every week to help treat multiple myeloma. This prescription drug is reserved for use in people whose cancer has progressed or become worse after at least two other chemotherapy treatments. Most people who receive this medicine will develop some type of side effect, such as fatigue, anemia, or nausea.
- Anemia (low red blood cell counts)
- Low platelet counts.